Clinical Trials Browser

Phase 2 × Has results × Chemotherapy-Related Cognitive Impairment × Clear all

NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Phase 2 Completed

22 enrolled 14 charts

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT01205503 2016-02-24

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Phase 2 Completed

32 enrolled 24 charts

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Lymphoma, Non-Hodgkin